Houlihan Lokey (HLI) to Release Quarterly Earnings on Wednesday

Houlihan Lokey (NYSE:HLI) is scheduled to release its earnings data after the market closes on Wednesday, October 30th. Analysts expect Houlihan Lokey to post earnings of $1.31 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Houlihan Lokey (NYSE:HLI) last issued its earnings results on Tuesday, July 30th. The financial services provider reported $1.22 EPS for the quarter, hitting analysts’ consensus estimates of $1.22. The company had revenue of $514.00 million for the quarter, compared to analysts’ expectations of $508.70 million. Houlihan Lokey had a net margin of 15.30% and a return on equity of 18.80%. The firm’s revenue was up 23.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.89 EPS. On average, analysts expect Houlihan Lokey to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Houlihan Lokey Trading Down 1.2 %

HLI opened at $166.01 on Monday. The business’s 50-day moving average price is $159.39 and its 200-day moving average price is $144.31. Houlihan Lokey has a 12 month low of $94.67 and a 12 month high of $175.21. The company has a market cap of $11.54 billion, a P/E ratio of 36.81 and a beta of 0.66.

Houlihan Lokey Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Sunday, September 15th. Investors of record on Tuesday, September 3rd were paid a $0.57 dividend. The ex-dividend date was Tuesday, September 3rd. This represents a $2.28 annualized dividend and a dividend yield of 1.37%. Houlihan Lokey’s payout ratio is presently 50.55%.

Insider Activity

In related news, General Counsel Christopher M. Crain sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total value of $155,290.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gillian Beth Zucker sold 200 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $152.49, for a total value of $30,498.00. Following the completion of the transaction, the director now directly owns 7,001 shares in the company, valued at $1,067,582.49. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 9,917 shares of company stock valued at $1,513,129 over the last three months. Insiders own 23.68% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on HLI. UBS Group lifted their price objective on Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. dropped their price target on Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 31st. Morgan Stanley increased their price objective on Houlihan Lokey from $146.00 to $163.00 and gave the stock an “equal weight” rating in a report on Monday, September 23rd. Keefe, Bruyette & Woods reissued a “market perform” rating and set a $154.00 price objective (up previously from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. Finally, Wells Fargo & Company started coverage on shares of Houlihan Lokey in a research report on Thursday, September 12th. They issued an “underweight” rating and a $149.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $157.00.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.